Market closed
Medtronic/$MDT
Medtronic shares are trading higher after the company announced positive clinical outcomes and strong performance of its Evolut TAVR system in low-risk aortic stenosis patients.
3 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Medtronic
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.
Ticker
$MDT
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Galway, Ireland
Employees
95,000
Website
Medtronic Metrics
BasicAdvanced
$112B
26.80
$3.27
0.82
$2.79
3.20%
Price and volume
Market cap
$112B
Beta
0.82
52-week high
$96.25
52-week low
$75.96
Average daily volume
8.3M
Dividend rate
$2.79
Financial strength
Current ratio
1.901
Quick ratio
1.186
Long term debt to equity
48.342
Total debt to equity
53.627
Dividend payout ratio (TTM)
84.62%
Interest coverage (TTM)
8.90%
Management effectiveness
Return on assets (TTM)
4.66%
Return on equity (TTM)
8.44%
Valuation
Price to earnings (TTM)
26.796
Price to revenue (TTM)
3.419
Price to book
2.28
Price to tangible book (TTM)
-31.1
Price to free cash flow (TTM)
20.76
Dividend yield (TTM)
3.18%
Forward dividend yield
3.20%
Growth
Revenue change (TTM)
2.72%
Earnings per share change (TTM)
3.82%
3-year revenue growth (CAGR)
1.46%
3-year earnings per share growth (CAGR)
-3.41%
3-year dividend per share growth (CAGR)
4.14%
What the Analysts think about Medtronic
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Medtronic stock.
Medtronic Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Medtronic Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Medtronic News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market closed
Upcoming events
Apr11
Medtronic
Dividend·Payment
$0.70
Per share
FAQs
What’s the current market cap for Medtronic stock?
Medtronic (MDT) has a market cap of $112B as of March 31, 2025.
What is the P/E ratio for Medtronic stock?
The price to earnings (P/E) ratio for Medtronic (MDT) stock is 26.8 as of March 31, 2025.
Does Medtronic stock pay dividends?
Yes, the Medtronic (MDT) stock pays dividends to shareholders. As of March 31, 2025, the dividend rate is $2.79 and the yield is 3.2%. Medtronic has a payout ratio of 84.62% on a trailing twelve-month basis.
When is the next Medtronic dividend payment date?
The next Medtronic (MDT) dividend payment is scheduled for April 11, 2025.
What is the beta indicator for Medtronic?
Medtronic (MDT) has a beta rating of 0.82. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.